Folate, vitamin B12, and homocysteine status: Findings of no relation between human papillomavirus persistence and cervical dysplasia

Nutrition

Volumn 19, Issue 6, 2003, Pages 497-502

  Sedjo, Rebecca L ^b   Fowler, Brenda M ^b   Schneider, Achim ^b   Henning, Susanne M ^b   Hatch, Kenneth ^b   Giuliano, Anna R ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b NONE

Author keywords

Folate; Homocysteine; Human papillomavirus persistence; Vitamin B12

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; ARTICLE; CORRELATION ANALYSIS; CYTOLOGY; DISEASE ASSOCIATION; ETHNIC GROUP; FEMALE; FOLIC ACID BLOOD LEVEL; HEALTH STATUS; HUMAN; INFECTION RISK; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; NUTRIENT; NUTRITIONAL STATUS; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE; UTERINE CERVIX DYSPLASIA; VIRUS DETECTION; VITAMIN BLOOD LEVEL; WART VIRUS;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRUS;

EID: 0038100268     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-9007(02)01096-1     Document Type: Article

References (45)

1. Bosch F.X., Manos M.M., Munoz N., et al. Prevalence of human papillomavirus in cervical cancer a worldwide perspective. International biological study on cervical cancer (IBSCC) study group . J Natl Cancer Inst. 87:1995;796.
2. Walboomers J.M., Jacobs M.V., Manos M.M., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 189:1999;12.
3. Franco E.L. Epidemiology of anogenital warts and cancer. Obstet Gynecol Clin North Am. 23:1996;597.
4. Ho G.Y., Burk R.D., Klein S., et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst. 87:1995;1365.
5. Ho G.Y., Bierman R., Beardsley L., Chang C.J., Burk R.D. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med. 338:1998;423.
6. Ho G.Y., Palan P.R., Basu J., et al. Viral characteristics of human papillomavirus infection and antioxidant levels as risk factors for cervical dysplasia. Int J Cancer. 78:1998;594.
7. Wheeler C.M., Greer C.E., Becker T.M., et al. Short-term fluctuations in the detection of cervical human papillomavirus DNA. Obstet Gynecol. 88:1996;261.
8. Moscicki A.B., Palefsky J., Smith G., Siboshski S., Schoolnik G. Variability of human papillomavirus DNA testing in a longitudinal cohort of young women. Obstet Gynecol. 82:1993;578.
9. Sedjo RL, Inserra P, Abrahamsen M, et al. HPV persistence and nutrients involved in the methylation pathway among a cohort of young women. Cancer Epidemiol Biomarkers Prev 2002;11:353.
10. Rosl F., Schwarz E. Regulation of E6 and E7 oncogenic transcription. Tommasino M. Papillomaviruses in human cancer role of E6 and E7 oncoproteins . 1997;25 Landes Bioscience and Chapman & Hall, Austin, TX.
11. Rosl F., Arab A., Klevenz B., zur Hausen H. The effect of DNA methylation on gene regulation of human papillomaviruses. J Gen Virol. 74:1993;791.
12. Bailey L.B., Gregory J.F. III. Folate metabolism and requirements. J Nutr. 129:1999;779.
13. Choi S.W., Mason J.B. Folate and carcinogenesis an integrated scheme . J Nutr. 130:2000;129.
14. Selhub J., Miller J.W. The pathogenesis of homocysteinemia interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine . Am J Clin Nutr. 55:1992;131.
15. Liu T., Soong S.J., Wilson N.P., et al. A case control study of nutritional factors and cervical dysplasia. Cancer Epidemiol Biomarkers Prev. 2:1993;525.
16. Kanetsky P.A., Gammon M.D., Mandelblatt J., et al. Dietary intake and blood levels of lycopene association with cervical dysplasia among non-Hispanic, Black women . Nutr Cancer. 31:1998;31.
17. Wideroff L., Potischman N., Glass A.G., et al. A nested case-control study of dietary factors and the risk of incident cytological abnormalities of the cervix. Nutr Cancer. 30:1998;130.
18. Brock K.E., Berry G., Mock P.A., et al. Nutrients in diet and plasma and risk of in situ cervical cancer. J Natl Cancer Inst. 80:1988;580.
19. Herrero R., Potischman N., Brinton L.A., et al. A case-control study of nutrient status and invasive cervical cancer. I. Dietary indicators. Am J Epidemiol. 134:1991;1335.
20. VanEenwyk J., Davis F.G., Colman N. Folate, vitamin C, and cervical intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev. 1:1992;119.
21. Ziegler R.G., Jones C.J., Brinton L.A., et al. Diet and the risk of in situ cervical cancer among White women in the United States. Cancer Causes Control. 2:1991;17.
22. Ziegler R.G., Brinton L.A., Hamman R.F., et al. Diet and the risk of invasive cervical cancer among White women in the United States. Am J Epidemiol. 132:1990;432.
23. Verreault R., Chu J., Mandelson M., Shy K. A case-control study of diet and invasive cervical cancer. Int J Cancer. 43:1989;1050.
24. Goodman M.T., McDuffie K., Hernandez B., et al. Association of methylenetetrahydrofolate reductase polymorphism c677t and dietary folate with the risk of cervical dysplasia. Cancer Epidemiol Biomarkers Prev. 10:2001;1275.
25. Buckley D.I., McPherson R.S., North C.Q., Becker T.M. Dietary micronutrients and cervical dysplasia in southwestern American Indian women. Nutr Cancer. 17:1992;179.
26. Kwasniewska A., Tukendorf A., Semczuk M. Folate deficiency and cervical intraepithelial neoplasia. Eur J Gynaecol Oncol. 18:1997;526.
27. Butterworth C.E. Jr, Hatch K.D., Macaluso M., et al. Folate deficiency and cervical dysplasia. JAMA. 267:1992;528.
28. Weinstein S.J., Ziegler R.G., Frongillo E.A. Jr, et al. Low serum and red blood cell folate are moderately, but nonsignificantly associated with increased risk of invasive cervical cancer in U.S. women. J Nutr. 131:2001;2040.
29. 12, and homocysteine. Cancer Epidemiol Biomarkers Prev. 9:2000;761.
30. Potischman N., Brinton L.A., Laiming V.A., et al. A case-control study of serum folate levels and invasive cervical cancer. Cancer Res. 51:1991;4785.
31. 12, and cysteine as markers of cervical dysplasia. Cancer. 89:2000;376.
32. Ziegler R.G., Weinstein S.J., Fear T.R. Nutritional and genetic inefficiencies in one-carbon metabolism and cervical cancer risk. J Nutr. 132:2002;2345S.
33. Weinstein S.J., Ziegler R.G., Selhub J., et al. Elevated serum homocysteine levels and increased risk of invasive cervical cancer in US women. Cancer Causes Control. 12:2001;317.
34. Thomson S.W., Heimburger D.C., Cornwell P.E., et al. Effect of total plasmahomocysteine on cervical dysplasia risk. Nutr Cancer. 37:2000;128.
35. Childers J.M., Chu J., Voigt L.F., et al. Chemoprevention of cervical cancer withfolic acid a phase III southwest oncology group intergroup study . CancerEpidemiol Biomarkers Prev. 4:1995;155.
36. Butterworth C.E., Hatch K.D., Gore H., Mueller H., Krumdieck C.L. Improvement in cervical dysplasia associated with folic acid therapy in users of oral contraceptives. Am J Clin Nutr. 35:1982;73.
37. Butterworth C.E. Jr, Hatch K.D., Soong S.J., et al. Oral folic acid supplementation for cervical dysplasia a clinical intervention trial . Am J Obstet Gynecol. 166:1992;803.
38. Giuliano A.R., Papenfuss M., Nour M., et al. Antioxidant nutrients associations with persistent human papillomavirus infection . Cancer Epidemiol Biomarkers Prev. 6:1997;917.
39. Manos M.M., Ting Y., Wright D.K., Lewis A.J., Broker T.R. Use of plolymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells. 7:1989;209.
40. Refsum H., Helland S., Ueland P.M. Radioenzymic determination of homocysteine in plasma and urine. Clin Chem. 31:1985;624.
41. Piyathilake C.J., Macaluso M., Johanning G.L., et al. Methylenetetrahydrofolate reductase (MTHFR) polymorphism increases the risk of cervical intraepithelial neoplasia. Anticancer Res. 20:2000;1751.
42. Schlecht N.F., Kulaga S., Robitaille J., et al. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA. 286:2001;3106.
43. Franco E.L., Villa L.L., Sobrinho J.P., et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis. 180:1999;1415.
44. Giuliano A.R., Papenfuss M., Schneider A., Nour M., Hatch K. Risk factors for high-risk type human papillomavirus infection among Mexican-American women. Cancer Epidemiol Biomarkers Prev. 8:1999;615.
45. Senti F.R., Pilch S.M. Analysis of folate data from the second National Health and Nutrition Examination Survey (NHANES II). J Nutr. 115:1985;1398.